Arndt Vogel
@arndtvogel
Clinician-scientist, focused on liver cancer & precision oncology, Toronto General Hospital/Princess Margaret Cancer Center 🇨🇦/MHH🇩🇪
ID: 1211086357
23-02-2013 08:40:33
1,1K Tweet
6,6K Followers
440 Following
Pembrolizumab + CAPOX /bevacizumab in MSS CRC and a high immune infiltrate #ESMO24 🔎POCHI trial 👉ORR 74%, DRC 100%, 5 CR 👉12-mo PFS rate 51% 👉2-yr OS rate 80% 👉AEs ≥3 70% 🧐IMMUNOSCORE and TuLIS score (18% of pts) to select ICI in mCRC? ESMO - Eur. Oncology #ESMOAmbassadors